- Home
- ADC vs RGC Comparison
ADC vs RGC Comparison
Compare ADC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADC
- RGC
- Stock Information
- Founded
- ADC 1971
- RGC 2014
- Country
- ADC United States
- RGC Hong Kong
- Employees
- ADC N/A
- RGC N/A
- Industry
- ADC Real Estate Investment Trusts
- RGC Medicinal Chemicals and Botanical Products
- Sector
- ADC Real Estate
- RGC Health Care
- Exchange
- ADC Nasdaq
- RGC Nasdaq
- Market Cap
- ADC 8.0B
- RGC 6.6B
- IPO Year
- ADC 1994
- RGC 2021
- Fundamental
- Price
- ADC $75.23
- RGC $16.36
- Analyst Decision
- ADC Buy
- RGC
- Analyst Count
- ADC 12
- RGC 0
- Target Price
- ADC $81.45
- RGC N/A
- AVG Volume (30 Days)
- ADC 1.1M
- RGC 225.6K
- Earning Date
- ADC 10-21-2025
- RGC 10-24-2025
- Dividend Yield
- ADC 4.10%
- RGC N/A
- EPS Growth
- ADC N/A
- RGC N/A
- EPS
- ADC 1.68
- RGC N/A
- Revenue
- ADC $659,753,000.00
- RGC N/A
- Revenue This Year
- ADC $15.42
- RGC N/A
- Revenue Next Year
- ADC $10.73
- RGC N/A
- P/E Ratio
- ADC $44.58
- RGC N/A
- Revenue Growth
- ADC 13.16
- RGC N/A
- 52 Week Low
- ADC $67.58
- RGC $0.09
- 52 Week High
- ADC $79.65
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- ADC 67.39
- RGC 45.49
- Support Level
- ADC $69.76
- RGC $16.00
- Resistance Level
- ADC $75.99
- RGC $19.30
- Average True Range (ATR)
- ADC 1.06
- RGC 1.58
- MACD
- ADC 0.56
- RGC 0.12
- Stochastic Oscillator
- ADC 87.80
- RGC 9.33
About ADC Agree Realty Corporation
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.